Akari Therapeutics, Plc Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
Akari Therapeutics, Plc (AKTX) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number of 1.36 million shares as of 2024-06-30, per its 8-K filed 2024-09-06.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber · last filed 2024-09-06
- 2024-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 1.36M shares.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 1.70M shares.
- 2023-02-28: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 335.65K shares.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 1.75M shares; Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number as first filed 513.67M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number as first filed |
|---|---|---|
| 2024-06-30 | 1.36M shares 8-K · filed 2024-09-06 | |
| 2023-12-31 | 1.70M shares 8-K · filed 2024-09-06 | |
| 2023-02-28 | 335.65K shares 8-K · filed 2024-09-06 | |
| 2022-12-31 | 1.75M shares 8-K · filed 2024-09-06 | 513.67M shares 20-F · filed 2023-05-01 |
| 2022-06-30 | 379.81M shares 6-K · filed 2022-09-27 | |
| 2021-12-31 | 142.95M shares 6-K · filed 2022-09-27 | |
| 2021-06-30 | 123.45M shares 6-K · filed 2021-09-22 | |
| 2020-12-31 | 112.65M shares 20-F · filed 2022-05-16 | |
| 2020-06-30 | 112.65M shares 6-K · filed 2020-09-01 | |
| 2019-12-31 | 94.35M shares 20-F · filed 2022-05-16 | |
| 2019-06-30 | 100.42M shares 6-K · filed 2019-08-29 | |
| 2018-12-31 | 94.10M shares 20-F · filed 2022-05-16 | |
| 2018-06-30 | 63.56M shares 6-K · filed 2018-09-27 | |
| 2017-12-31 | 90.06M shares 20-F · filed 2021-04-21 | 89.61M shares 20-F · filed 2018-07-18 |
| 2017-06-30 | 72.52M shares 6-K · filed 2017-08-10 | |
| 2016-12-31 | 79.37M shares 20-F · filed 2020-03-31 | |
| 2016-06-30 | 76.93M shares 6-K · filed 2017-04-14 | |
| 2016-03-31 | 72.36M shares 10-Q · filed 2016-05-12 | |
| 2015-12-31 | 61.36M shares 20-F · filed 2019-04-23 | |
| 2015-06-30 | 2.70M shares 10-Q · filed 2015-08-12 | |
| 2015-03-31 | 2.90M shares 10-Q · filed 2015-05-12 | |
| 2014-12-31 | 2.90M shares 10-Q · filed 2015-08-12 | |
| 2013-12-31 | 2.20M shares 10-K · filed 2015-02-11 | |
| 2012-12-31 | 770.53K shares 10-K · filed 2015-02-11 | |
| 2011-12-31 | 360.53K shares 20-F · filed 2014-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |